Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Simultaneously targeting lysosomal enzyme and KRAS-MAPK pathway eradicates pancreatic tumors in preclinical models

2.

How artificial intelligence could significantly improve the prognosis for cancer patients.

3.

Q&A: Why adolescents and young adults with cancer are falling behind

4.

Breast cancer surgery: Study finds overnight hospital stay not important for older patients

5.

The pancreatic ductal adenocarcinoma mRNA vaccine holds promise for preventing relapse.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot